GENÉTICA MOLECULAR EN ONCOHEMATOLOGÍA

Foto de GENÉTICA MOLECULAR EN ONCOHEMATOLOGÍA

Foto de Dana–Farber Cancer Institute

Dana–Farber Cancer Institute

Boston, Estados Unidos

Publications en collaboration avec des chercheurs de Dana–Farber Cancer Institute (6)

2024

Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis
American Journal of Hematology

2021

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
Blood Cancer Journal, Vol. 11, Núm. 7

2020

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
Leukemia, Vol. 34, Núm. 6, pp. 1599-1612
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792

2019

DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains
Experimental Hematology, Vol. 72, pp. 9-13

2016

FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia
American Journal of Hematology, Vol. 91, Núm. 10, pp. 978-983